Federated Hermes’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6	Closed	-$9	–	2148
2024 Q3	$9	Buy	6 +5	+500%	+$9	﹤0.01%	2049
2024 Q2	$2	Buy	+1	New	+$2	﹤0.01%	2017
2023 Q4	–	Sell	-16,493	Closed	-$18K	–	2129
2023 Q3	$18K	Buy	16,493 +6,925	+72%	+$12.2K	﹤0.01%	1776
2023 Q2	$21.9K	Buy	+9,568	New	+$25.4K	﹤0.01%	1762
2021 Q3	–	Sell	-21,505	Closed	-$99K	–	2282
2021 Q2	$99K	Buy	21,505 +2,083	+11%	+$10K	﹤0.01%	1795
2021 Q1	$114K	Sell	19,422 -11,548	-37%	-$80K	﹤0.01%	1773
2020 Q4	$106K	Sell	30,970 -1,678,806	-98%	-$3.2M	﹤0.01%	1748
2020 Q3	$2.46M	Hold	1,709,776	–	–	0.01%	914
2020 Q2	$3.41M	Buy	1,709,776 +992,069	+138%	+$1.94M	0.01%	814
2020 Q1	$1.4M	Buy	717,707 +605,310	+539%	+$1.8M	﹤0.01%	1006
2019 Q4	$466K	Buy	112,397 +112,326	+158,206%	+$432K	﹤0.01%	1466
2019 Q3	$1K	Sell	71 -9,791	-99%	-$30.3K	﹤0.01%	2116
2019 Q2	$62K	Sell	9,862 -2,749	-22%	-$16.5K	﹤0.01%	1649
2019 Q1	$70K	Buy	12,611 +11,721	+1,317%	+$71.2K	﹤0.01%	1626
2018 Q4	$6K	Buy	+890	New	+$7.21K	﹤0.01%	1952
2016 Q4	–	Sell	-4,294	Closed	-$78K	–	2147
2016 Q3	$78K	Buy	+4,294	New	+$69.1K	﹤0.01%	1583